BPG is committed to discovery and dissemination of knowledge
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Mikhail N. Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes. World J Diabetes 2014; 5(6): 854-859 [PMID: 25512787 DOI: 10.4239/wjd.v5.i6.854]
Corresponding Author of This Article
Nasser Mikhail, MD, MSc, Department of Medicine, Endocrine Division, OliveView-UCLA Medical Center, 14445 Olive View Dr, Sylmar, CA 91342, United States. nmikhail@dhs.lacounty.gov
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7698)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2014 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Total Visits of This Article
2019 | Number of total visits
Rank | Countries/Territories | Count | Percent |
1 | 13 | 100% |